Loading company…
PAREXEL provides clinical research and biopharmaceutical services.
PAREXEL provides clinical research, consulting, outsourcing, portfolio management and clinical development services to the biopharmaceutical sector. Its therapeutic areas include oncology, cardiovascular and metabolic conditions, CNS, infectious disease, ophthalmology, respiratory, rare diseases and others. Founded in 1982, the company was acquired by EQT and Goldman Sachs Asset Management from Pamplona Capital Management in July 2021 for USD 8.5 billion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in